Alkermes plc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.5B | $1.6B | $1.7B | $1.1B | $1.2B |
| Cost of revenue | $196.5M | $245.3M | $253.0M | $218.1M | $197.3M |
| Selling, general & administrative | $701.5M | $645.2M | $689.8M | $590.8M | $549.6M |
| Research and development | $324.0M | $245.3M | $270.8M | $272.7M | $290.9M |
| Operating income | $254.0M | $420.6M | $414.1M | -$6.1M | $97.7M |
| Interest expense | $12.3M | $22.6M | $23.0M | $13.0M | $11.2M |
| Pretax income | $291.4M | $443.8M | $421.5M | -$31.1M | $87.7M |
| Income tax expense | $49.8M | $71.6M | -$97.6M | $2.0M | $11.3M |
| Net income | $241.7M | $367.1M | $355.8M | -$158.3M | -$48.2M |
| Balance Sheet | |||||
| Cash and equivalents | $388.6M | $291.1M | $457.5M | $292.5M | $337.5M |
| Current assets | $1.9B | $1.4B | $1.5B | $1.1B | $1.1B |
| Total assets | $2.5B | $2.1B | $2.1B | $2.0B | $2.0B |
| Current liabilities | $543.4M | $465.2M | $520.2M | $497.7M | $471.3M |
| Total liabilities | $667.7M | $590.6M | $933.5M | $920.2M | $911.9M |
| Stockholders' equity | $1.8B | $1.5B | $1.2B | $1.0B | $1.1B |
| Cash Flow Statement | |||||
| Cash from operations | $520.8M | $439.1M | $401.4M | $21.0M | $101.7M |
| Depreciation and amortization | $27.2M | $28.5M | $74.9M | $77.9M | $78.7M |
| Stock-based compensation | $98.7M | $96.6M | $100.9M | $94.3M | $87.6M |
| Capital expenditure | $40.4M | $33.5M | $48.0M | $38.3M | $28.0M |
| Free cash flow | $480.3M | $405.6M | $353.3M | -$17.2M | $73.7M |
| Share repurchases | — | $200.3M | — | — | — |
Shares outstanding 166.7M · Free float 94.5%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.